Kaveh Roshanbinfar

Mr. Kaveh Roshanbinfar

Experimental Renal and Cardiovascular Research, Department of Nephropathology, Institute of Pathology, Friedrich‐Alexander‐Universität Erlangen‐Nürnberg (FAU), Muscle Research Center Erlangen (MURCE), 91054 Erlangen, Germany
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2018 in Advanced Functional Materials
Verified
Journal Article
Open access
PDF file
KRKaveh Roshanbinfar
Kaveh Roshanbinfar
LVLena Vogt
Lena Vogt
BGBoris Greber
Boris Greber
SDSebastian Diecke
Sebastian Diecke
ABAldo R. Boccaccini
Aldo R. Boccaccini
Felix EngelFelix Engel
Felix Engel
Cardiac tissue engineering is a promising strategy to treat heart failure. Yet, several issues remain to be resolved including the prevention of arrhythmia caused by inefficient electrical coupling within the graft and between graft and host tissue. Here, a biohybrid hydrogel composed of collagen, alginate, and electroconductive poly(3,4‐ethylenedioxythiophene):polystyrene sulfonate (PEDOT:PSS) is developed that exhibits extracellular matrix–mimetic fibrous structures and enhanced electrical coupling as well and cardiomyocyte maturation. Presence of PEDOT:PSS in the hydrogel improves electrical conductivity and prevents arrhythmia of tissue constructs containing neonatal rat cardiomyocytes. Moreover, it results in increasing beating frequencies reaching more than 200 beats min−1 endogenous frequencies. In addition, cardiomyocytes exhibit increased alignment and density in these constructs, improved sarcomere organization, and enhanced connexin 43 expression, suggesting maturation of the cardiac tissue. Importantly, the here developed electroconductive biohybrid hydrogels also improve maturation and beating properties of human‐induced pluripotent stem cell–derived cardiomyocytes. These cells exhibit 1.9 µm near adult sarcomeric length, enhanced beating frequency, increased speed of contraction, and larger contraction amplitude. Collectively, the data demonstrate the potential of this electroconductive biohybrid hydrogel to improve tissue engineering approaches to treat heart failure and possibly diseases of other electrically sensitive tissues.

15 December 2019 in Advanced Functional Materials
Verified
Journal Article
Open access
PDF file
KRKaveh Roshanbinfar
Kaveh Roshanbinfar
LVLena Vogt
Lena Vogt
FRFlorian Ruther
Florian Ruther
JRJudith A. Roether
Judith A. Roether
Aldo R. BoccacciniAldo R. Boccaccini
Aldo R. Boccaccini
Felix EngelFelix Engel
Felix Engel
Cardiac tissue engineering is a promising strategy to prevent functional deterioration or even to enhance cardiac function upon myocardial infarction. Here, electrospun fiber mats containing different combinations of electrically conductive polyaniline, collagen, and/or hyaluronic acid are assessed regarding material properties and compatibility with cardiomyocyte attachment and function. Microstructure analysis reveals that collagen fiber mats contain a wide range of fiber diameters after crosslinking (from ≈300 nm to ≈5 µm); all other fiber mats contain fibers in the range of ≈120 to ≈300 nm. Fiber mats exhibit comparable electrical conductivity to and greater mechanical properties than the native human myocardium, which is considered beneficial. Cell–matrix interaction analysis utilizing postnatal rat cardiomyocytes reveals that the fiber mats are non‐cytotoxic and permit cell attachment and contraction. Fiber mats containing collagen (9.89%), hyaluronic acid (1.1%), and polyaniline (PANi, 1.34%) exhibit the most favorable properties with longer contraction time, higher contractile amplitude, and lower beating rates. Improved contraction is accompanied by increased connexin 43 expression. Importantly, this fiber mat is a suitable material for human‐induced pluripotent stem cell–derived cardiomyocytes regarding cytotoxicity, cell attachment, and function. Collectively, these data demonstrate that fiber mats made of collagen, hyaluronic acid, and polyaniline are promising materials for cardiac tissue engineering.

12 July 2019 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
KRKaveh Roshanbinfar
Kaveh Roshanbinfar
ZMZahra Mohammadi
Zahra Mohammadi
AMAbdorreza Mesgar
Abdorreza Mesgar
MDMohammad Mehdi Dehghan
Mohammad Mehdi Dehghan
OVOommen Varghese
Oommen Varghese
Felix EngelFelix Engel
Felix Engel
Biohybrid hydrogels consisting of solubilized nanostructured pericardial matrix and electroconductive positively charged hydrazide-conjugated carbon nanotubes provide a promising material for stem cell-based cardiac tissue engineering.

3 May 2024 in Advanced Materials
Verified
Journal Article
Open access
KRKaveh Roshanbinfar
Kaveh Roshanbinfar
MSMiriam Schiffer
Miriam Schiffer
ECEsther Carls
Esther Carls
MAMiriam Angeloni
Miriam Angeloni
MKMaria Koleśnik‐Gray
Maria Koleśnik‐Gray
Felix EngelFelix Engel
Felix Engel
Myocardial infarction (MI) causes cell death, disrupts electrical activity, triggers arrhythmia, and results in heart failure, whereby 50–60% of MI‐associated deaths manifest as sudden cardiac deaths (SCD). The most effective therapy for SCD prevention is implantable cardioverter defibrillators (ICDs). However, ICDs contribute to adverse remodeling and disease progression and do not prevent arrhythmia. This work develops an injectable collagen‐PEDOT:PSS (poly(3,4‐ethylenedioxythiophene) polystyrene sulfonate) hydrogel that protects infarcted hearts against ventricular tachycardia (VT) and can be combined with human induced pluripotent stem cell (hiPSC)‐cardiomyocytes to promote partial cardiac remuscularization. PEDOT:PSS improves collagen gel formation, micromorphology, and conductivity. hiPSC‐cardiomyocytes in collagen‐PEDOT:PSS hydrogels exhibit near‐adult sarcomeric length, improved contractility, enhanced calcium handling, and conduction velocity. RNA‐sequencing data indicate enhanced maturation and improved cell‐matrix interactions. Injecting collagen‐PEDOT:PSS hydrogels in infarcted mouse hearts decreases VT to the levels of healthy hearts. Collectively, collagen‐PEDOT:PSS hydrogels offer a versatile platform for treating cardiac injuries.

10 April 2023 in Advanced Healthcare Materials
Verified
Journal Article
Open access
KRKaveh Roshanbinfar
Kaveh Roshanbinfar
MKMaria Kolesnik‐Gray
Maria Kolesnik‐Gray
MAMiriam Angeloni
Miriam Angeloni
SSStefan Schruefer
Stefan Schruefer
MFMaren Fiedler
Maren Fiedler
Felix EngelFelix Engel
Felix Engel
Cardiac tissue engineering is a promising strategy to prevent heart failure. However, several issues remain unsolved, including efficient electrical coupling and incorporating factors to enhance tissue maturation and vascularization. Herein, a biohybrid hydrogel that enhances beating properties of engineered cardiac tissues and allows drug release concurrently is developed. Gold nanoparticles (AuNPs) with different sizes (18–241 nm) and surface charges (33.9–55.4 mV) are synthesized by reducing gold (III) chloride trihydrate using branched polyethyleneimine (bPEI). These nanoparticles increase gel stiffness from ≈91 to ≈146 kPa, enhance electrical conductivity of collagen hydrogels from ≈40 to 49–68 mS cm−1, and allow slow and steady release of loaded drugs. Engineered cardiac tissues based on bPEI‐AuNP‐collagen hydrogels and either primary or human induced pluripotent stem cell (hiPSC)‐derived cardiomyocytes show enhanced beating properties. hiPSC‐derived cardiomyocytes exhibit more aligned and wider sarcomeres in bPEI‐AuNP‐collagen hydrogels compared to collagen hydrogels. Furthermore, the presence of bPEI‐AuNPs result in advanced electrical coupling evidenced by synchronous and homogenous calcium flux throughout the tissue. RNA‐seq analyses are in agreement with these observations. Collectively, this data demonstrate the potential of bPEI‐AuNP‐collagen hydrogels to improve tissue engineering approaches to prevent heart failure and possibly treat diseases of other electrically sensitive tissues.

10 February 2025 in Biomaterials
Verified
Journal Article
Open access
KRKaveh Roshanbinfar
Kaveh Roshanbinfar
AEAustin Donnelly Evans
Austin Donnelly Evans
SSSumanta Samanta
Sumanta Samanta
MKMaria Kolesnik-Gray
Maria Kolesnik-Gray
MFMaren Fiedler
Maren Fiedler
OVOommen Varghese
Oommen Varghese
Biofabrication represents a promising technique for creating tissues for regeneration or as models for drug testing. Collagen-based hydrogels are widely used as suitable matrix owing to their biocompatibility and tunable mechanical properties. However, one major challenge is that the encapsulated cells interact with the collagen matrix causing construct shrinkage. Here, we present a hydrogel with high shape fidelity, mimicking the major components of the extracellular matrix. We engineered a composite hydrogel comprising gallic acid (GA)-functionalized hyaluronic acid (HA), collagen I, and HA-coated multiwall carbon nanotubes (MWCNT). This hydrogel supports cell encapsulation, exhibits shear-thinning properties enhancing injectability and printability, and importantly significantly mitigates shrinkage when loaded with human fibroblasts compared to collagen I hydrogels (∼20 % vs. > 90 %). 3D-bioprinted rings utilizing human fibroblast-loaded inks maintain their shape over 7 days in culture. Furthermore, inclusion of HAGA into collagen I hydrogels increases mechanical stiffness, radical scavenging capability, and tissue adhesiveness. Notably, the here developed hydrogel is also suitable for human induced pluripotent stem cell-derived cardiomyocytes and allows printing of functional heart ventricles responsive to pharmacological treatment. Cardiomyocytes behave similar in the newly developed hydrogels compared to collagen I, based on survival, sarcomere appearance, and calcium handling. Collectively, we developed a novel material to overcome the challenge of post-fabrication matrix shrinkage conferring high shape fidelity.